Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **protein N-terminal amino group** is the free amine group (-NH₂) located at the start (N-terminus) of a protein or polypeptide chain[1][3][5]. It is a universal feature of all translated proteins, typically derived from the first amino acid incorporated during translation, which in eukaryotes is usually methionine[1][3]. This group plays crucial roles in determining protein identity, function, stability, and fate within the cell. The N-terminal amino group can be modified post-translationally through acetylation, methylation, myristoylation, ubiquitination, and other processes, some of which have regulatory roles in protein function and degradation[2][3]. The specific identity or modification state of the N-terminal amino group can affect a protein's half-life (N-end rule), localization, and interactions, but the group itself is not a conventional drug target, enzyme, or receptor[1][2].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein N-terminal amino group (null).